Article
Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.
Journal of virology - 1 Jun 2010
Kaufman David R, Bivas-Benita Maytal, Simmons Nathaniel L, Miller Darby, Barouch Dan H
Abstract excerpt
Candidate HIV-1 vaccine regimens utilizing intramuscularly (i.m.) administered recombinant adenovirus (rAd)-based vectors can induce potent mucosal cellular immunity. However, the degree to which mucosal rAd vaccine routing might alter the quality and anatomic distribution of vaccine-elicited CD8(+) T lymphocytes remains unclear. We show that the route of vaccination critically impacts not only the magnitude but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
